Global Cell Culture Media for Vaccine Market Research Report 2022

Cell Culture Media are used to provide nutrients for cells growth in research, diagnostic and manufacturing applications. Typical cell culture media contain a mixture of defined nutrients dissolved in a buffered physiological saline solution. In cell culture, media are used to facilitate the growth of cells. Media are water-based liquids that can be provided in liquid or in dry powder format. Dry powder media has to be hydrated with water or with process liquids. Process liquids are water-based buffers and saline solutions which facilitate the cell culture process and ensure that the cell culture environment remains at a constant pH.
Due to the COVID-19 pandemic, the global Cell Culture Media for Vaccine market size is estimated to be worth US$ 915 million in 2021 and is forecast to a readjusted size of US$ 1537.1 million by 2028 with a CAGR of 7.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Cell Culture Media for Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Cell Culture Media for Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global Cell Culture Media for Vaccine key players include Thermo Fisher, Merck, Corning, Cytiva, Lonza, etc. Global top five manufacturers hold a share about 80%. Americas is the largest market, with a share about 41%, followed by Europe and APAC, both have a share over 54 percent. In terms of product, Serum-free is the largest segment, with a share over 78%. And in terms of application, the largest application is Human Vaccine, followed by Animal Vaccine, etc.
This report focuses on Cell Culture Media for Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cell Culture Media for Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Cell Culture Media for Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by End User. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
With Serum
Serum-free
Segment by End User
Human Vaccine
Animal Vaccine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermo Fisher
Merck
Corning
Cytiva
Lonza
Fujifilm
Sartorius Stedim Biotech
HiMedia Laboratories
ProCellTM
Jianshun Biosicences
Shanghai OPM Biosciences
Zhenge Biotech